Contact
searchSearch
HMP Global
Login

Child & Adolescent Psychiatry

A group of foods rich in omega-3 fatty acids, including fish and nuts
News
Omega-3 Eases Schizotypal Personality Disorder Symptoms in Children
02/21/2024
Jolynn Tumolo
Omega-3 supplementation, both in combination with cognitive behavioral therapy (CBT) and alone, decreased symptoms of schizotypal personality disorder in children.
Omega-3 supplementation, both in combination with cognitive behavioral therapy (CBT) and alone, decreased symptoms of schizotypal personality disorder in children.
Omega-3 supplementation, both in...
02/21/2024
Psych Congress Network
brain network
News
Comorbid Tics, Stereotypies Common in Typically Developing Patients, Review Finds
01/09/2024
Jolynn Tumolo
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often...
01/09/2024
Psych Congress Network
Psychiatry Family
News
Broader Psychopathology Comorbidity May Fuel Transmission of Conditions to Offspring
12/20/2023
Jolynn Tumolo
The intergenerational transmission of psychiatric conditions appears to be mostly attributable to broader psychopathology comorbidity than specific conditions, suggest study results.
The intergenerational transmission of psychiatric conditions appears to be mostly attributable to broader psychopathology comorbidity than specific conditions, suggest study results.
The intergenerational...
12/20/2023
Psych Congress Network
Transforming ADHD Care: Viloxazine ER vs Atomoxetine Roundtable Discussion
Family-Based Primary Care Treatment Shows Stronger Weight Loss Outcomes
News
Family-Based Primary Care Treatment Shows Stronger Weight Loss Outcomes
06/14/2023
Evi Arthur
Family-based treatment for childhood overweight and obesity was found to be successful in pediatric primary care settings and showed improved weight outcomes, according to a randomized clinical trial published in JAMA.
Family-based treatment for childhood overweight and obesity was found to be successful in pediatric primary care settings and showed improved weight outcomes, according to a randomized clinical trial published in JAMA.
Family-based treatment for...
06/14/2023
Psych Congress Network
News
Suicidal Behavior Increasing in US Youth, Meta-Analysis Finds
02/23/2023
Evi Arthur
Suicidal behavior and ideation increasing, particularly in older children and boys.
Suicidal behavior and ideation increasing, particularly in older children and boys.
Suicidal behavior and ideation...
02/23/2023
Psych Congress Network
News
Antipsychotic Prescribing for Children, Adolescents Doubled Over 20 Years
01/25/2023
Jolynn Tumolo
Over 2 decades, the proportion of antipsychotics prescribed to children and adolescents in England doubled.
Over 2 decades, the proportion of antipsychotics prescribed to children and adolescents in England doubled.
Over 2 decades, the proportion...
01/25/2023
Psych Congress Network
News
Emotional Maltreatment Strongly Linked to Psychiatric Disorders in Children
01/19/2023
Jolynn Tumolo
Emotional maltreatment may have stronger effects on the psyche of the children and adolescents than physical abuse and neglect, suggest study results published online ahead of print in the journal Child Maltreatment.
Emotional maltreatment may have stronger effects on the psyche of the children and adolescents than physical abuse and neglect, suggest study results published online ahead of print in the journal Child Maltreatment.
Emotional maltreatment may have...
01/19/2023
Psych Congress Network
News
Preteen Screen Time Linked With Heightened Risk of OCD
12/16/2022
Tom Valentino
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing...
12/16/2022
Addiction Professional
From Addiction Professional
News
Children May Be Especially Vulnerable to Disturbed Sleep, Depressive Symptoms Spirals
09/13/2022
Jolynn Tumolo
Significant bidirectional associations and cascade processes between depressive symptoms and disturbed sleep occur in children through age 12.
Significant bidirectional associations and cascade processes between depressive symptoms and disturbed sleep occur in children through age 12.
Significant bidirectional...
09/13/2022
Psych Congress Network
News
Antipsychotics During Pregnancy Do Not Hinder Children’s Test Performance
08/22/2022
Jolynn Tumolo
Antipsychotic prescriptions during pregnancy did not appear to be associated with standardized test scores in offspring.
Antipsychotic prescriptions during pregnancy did not appear to be associated with standardized test scores in offspring.
Antipsychotic prescriptions...
08/22/2022
Psych Congress Network

News Articles

A group of foods rich in omega-3 fatty acids, including fish and nuts
News
Omega-3 Eases Schizotypal Personality Disorder Symptoms in Children
02/21/2024
Jolynn Tumolo
Omega-3 supplementation, both in combination with cognitive behavioral therapy (CBT) and alone, decreased symptoms of schizotypal personality disorder in children.
Omega-3 supplementation, both in combination with cognitive behavioral therapy (CBT) and alone, decreased symptoms of schizotypal personality disorder in children.
Omega-3 supplementation, both in...
02/21/2024
Psych Congress Network
brain network
News
Comorbid Tics, Stereotypies Common in Typically Developing Patients, Review Finds
01/09/2024
Jolynn Tumolo
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often co-occur in otherwise typically developing pediatric patients, according to a systematic literature review.
Tics and stereotypies often...
01/09/2024
Psych Congress Network
Psychiatry Family
News
Broader Psychopathology Comorbidity May Fuel Transmission of Conditions to Offspring
12/20/2023
Jolynn Tumolo
The intergenerational transmission of psychiatric conditions appears to be mostly attributable to broader psychopathology comorbidity than specific conditions, suggest study results.
The intergenerational transmission of psychiatric conditions appears to be mostly attributable to broader psychopathology comorbidity than specific conditions, suggest study results.
The intergenerational...
12/20/2023
Psych Congress Network
Family-Based Primary Care Treatment Shows Stronger Weight Loss Outcomes
News
Family-Based Primary Care Treatment Shows Stronger Weight Loss Outcomes
06/14/2023
Evi Arthur
Family-based treatment for childhood overweight and obesity was found to be successful in pediatric primary care settings and showed improved weight outcomes, according to a randomized clinical trial published in JAMA.
Family-based treatment for childhood overweight and obesity was found to be successful in pediatric primary care settings and showed improved weight outcomes, according to a randomized clinical trial published in JAMA.
Family-based treatment for...
06/14/2023
Psych Congress Network
News
Suicidal Behavior Increasing in US Youth, Meta-Analysis Finds
02/23/2023
Evi Arthur
Suicidal behavior and ideation increasing, particularly in older children and boys.
Suicidal behavior and ideation increasing, particularly in older children and boys.
Suicidal behavior and ideation...
02/23/2023
Psych Congress Network
News
Antipsychotic Prescribing for Children, Adolescents Doubled Over 20 Years
01/25/2023
Jolynn Tumolo
Over 2 decades, the proportion of antipsychotics prescribed to children and adolescents in England doubled.
Over 2 decades, the proportion of antipsychotics prescribed to children and adolescents in England doubled.
Over 2 decades, the proportion...
01/25/2023
Psych Congress Network
News
Emotional Maltreatment Strongly Linked to Psychiatric Disorders in Children
01/19/2023
Jolynn Tumolo
Emotional maltreatment may have stronger effects on the psyche of the children and adolescents than physical abuse and neglect, suggest study results published online ahead of print in the journal Child Maltreatment.
Emotional maltreatment may have stronger effects on the psyche of the children and adolescents than physical abuse and neglect, suggest study results published online ahead of print in the journal Child Maltreatment.
Emotional maltreatment may have...
01/19/2023
Psych Congress Network
News
Preteen Screen Time Linked With Heightened Risk of OCD
12/16/2022
Tom Valentino
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing obsessive-compulsive disorder (OCD) over a 2-year period increased by 15% for every hour per day they played video games and 11% for every hour they watched videos, according to University of California San...
The odds of preteens developing...
12/16/2022
Addiction Professional
News
Children May Be Especially Vulnerable to Disturbed Sleep, Depressive Symptoms Spirals
09/13/2022
Jolynn Tumolo
Significant bidirectional associations and cascade processes between depressive symptoms and disturbed sleep occur in children through age 12.
Significant bidirectional associations and cascade processes between depressive symptoms and disturbed sleep occur in children through age 12.
Significant bidirectional...
09/13/2022
Psych Congress Network
News
Antipsychotics During Pregnancy Do Not Hinder Children’s Test Performance
08/22/2022
Jolynn Tumolo
Antipsychotic prescriptions during pregnancy did not appear to be associated with standardized test scores in offspring.
Antipsychotic prescriptions during pregnancy did not appear to be associated with standardized test scores in offspring.
Antipsychotic prescriptions...
08/22/2022
Psych Congress Network
US FDA sign
News
FDA Approves Oveporexton for Adults With Narcolepsy Type 1
08/06/2026
Brionna Mendoza
The US FDA has approved oveporexton (ORZEYFUL), a first-in-class orexin treatment for narcolepsy type 1 (NT1) in adults.
The US FDA has approved oveporexton (ORZEYFUL), a first-in-class orexin treatment for narcolepsy type 1 (NT1) in adults.
The US FDA has approved...
08/06/2026
Psych Congress Network
FDA building
FDA Approval
FDA Approves Centanafadine for Pediatric and Adult ADHD
07/27/2026
Maria Mantas
The US Food and Drug Administration (FDA) has approved centanafadine (SIMTRIYO), a norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit/hyperactivity disorder (ADHD).
The US Food and Drug Administration (FDA) has approved centanafadine (SIMTRIYO), a norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI), for the treatment of attention-deficit/hyperactivity disorder (ADHD).
The US Food and Drug...
07/27/2026
Psych Congress Network
illustration of a brain
Research Summary
Repeated Low-Dose Oral Esketamine Did Not Increase BDNF in Treatment-Resistant Depression
07/21/2026
Maria Mantas
Patients with TRD receiving repeated, low-dose oral esketamine did not experience greater increases in serum BDNF than those receiving placebo, according to study findings.
Patients with TRD receiving repeated, low-dose oral esketamine did not experience greater increases in serum BDNF than those receiving placebo, according to study findings.
Patients with TRD receiving...
07/21/2026
Psych Congress Network
FDA approval stamp
FDA Alerts
FDA Accepts NDA for AXS-12 in Cataplexy Associated With Narcolepsy
07/16/2026
Maria Mantas
The US Food and Drug Administration (FDA) accepted Axsome Therapeutics’ New Drug Application (NDA) for AXS-12 (reboxetine) for cataplexy in narcolepsy.
The US Food and Drug Administration (FDA) accepted Axsome Therapeutics’ New Drug Application (NDA) for AXS-12 (reboxetine) for cataplexy in narcolepsy.
The US Food and Drug...
07/16/2026
Psych Congress Network
Rakesh Jain, MD, MPH
Rapid Reaction
Rapid Reactions: Eli Lilly Acquisition Highlights Momentum in Psychedelics for Mental Health
07/16/2026
Rakesh Jain, MD, MPH, RD; Maria Mantas
Rakesh Jain, MD, MPH, responds to news that Eli Lilly and Company plans to acquire AtaiBeckley Inc, expanding its presence in the emerging field of psychedelic-based treatments for depression and other psychiatric conditions.
Rakesh Jain, MD, MPH, responds to news that Eli Lilly and Company plans to acquire AtaiBeckley Inc, expanding its presence in the emerging field of psychedelic-based treatments for depression and other psychiatric conditions.
Rakesh Jain, MD, MPH, responds...
07/16/2026
Psych Congress Network
a stethoscope, pills, and brain
Research Summary
Biobehavioral Markers May Improve Antidepressant Response in Major Depressive Disorder
07/16/2026
Maria Mantas
Patients with MDD and favorable biobehavioral markers for sertraline and/or bupropion experienced higher antidepressant response rates than those with negative markers for both drugs.
Patients with MDD and favorable biobehavioral markers for sertraline and/or bupropion experienced higher antidepressant response rates than those with negative markers for both drugs.
Patients with MDD and favorable...
07/16/2026
Psych Congress Network
an illustration of a man sitting on the ground holding his head with his profile and brain in the background
Research Summary
iTBS Offers Short-Term Improvement in Major Depressive Disorder
07/10/2026
Brionna Mendoza
A randomized clinical trial found that 10 once-daily sessions of iTBS produced short-term improvement compared to sham in clinician-rated depressive symptoms among adults with recurrent major depressive disorder (MDD).
A randomized clinical trial found that 10 once-daily sessions of iTBS produced short-term improvement compared to sham in clinician-rated depressive symptoms among adults with recurrent major depressive disorder (MDD).
A randomized clinical trial...
07/10/2026
Psych Congress Network
pills spilling out of a tipped over pill bottle
News
US Veterans Study Links SGLT2 Inhibitors to Lower Dementia Risk in Older Adults With Psychiatric Disorders
07/01/2026
Maria Mantas
Sodium-glucose cotransporter 2 (SGLT2) inhibitor use was associated with a lower risk of incident all-cause dementia among older US veterans with mood and psychotic disorders. 
Sodium-glucose cotransporter 2 (SGLT2) inhibitor use was associated with a lower risk of incident all-cause dementia among older US veterans with mood and psychotic disorders. 
Sodium-glucose cotransporter 2...
07/01/2026
Psych Congress Network
A patient sits across from a doctor who has a clipboard and is filling out a phone
Research Summary
Single-Dose LSD Formulation Hits Primary Endpoint in Phase 3 MDD Trial
06/29/2026
Brionna Mendoza
DT120, a proprietary formulation of lysergide (LSD) for treatment of MDD, met both primary and key secondary endpoints in the phase 3 Emerge study.
DT120, a proprietary formulation of lysergide (LSD) for treatment of MDD, met both primary and key secondary endpoints in the phase 3 Emerge study.
DT120, a proprietary formulation...
06/29/2026
Psych Congress Network
a young woman lies awake in bed
News
Adolescent Insomnia and Daytime Sleepiness Linked to Depression Risk
06/25/2026
Maria Mantas
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression. 
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression. 
A 3-year longitudinal study...
06/25/2026
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Desiree Matthews, PHMNP-BC; Amber Hoberg, MSN, APRN, PMHNP-BC
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use